+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Care Diagnostics Market by Product Type (Instruments, Reagents, Software and Services), Application (Blood Gas and Electrolyte Analyzers, Cardiac Marker Tests, Hemostasis Testing), Technology, End User, Test Mode - Global Forecast 2025-2030- Product Image
Critical Care Diagnostics Market by Product Type (Instruments, Reagents, Software and Services), Application (Blood Gas and Electrolyte Analyzers, Cardiac Marker Tests, Hemostasis Testing), Technology, End User, Test Mode - Global Forecast 2025-2030- Product Image
Sale

Critical Care Diagnostics Market by Product Type (Instruments, Reagents, Software and Services), Application (Blood Gas and Electrolyte Analyzers, Cardiac Marker Tests, Hemostasis Testing), Technology, End User, Test Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337076
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The critical care diagnostics market is advancing rapidly as technology, point-of-care integration, and cross-disciplinary innovation transform how urgent clinical decisions are made. For senior decision-makers seeking to optimize outcomes, a deep understanding of evolving segment needs, global supply dynamics, and competitive strategies is pivotal.

Market Snapshot: Critical Care Diagnostics Market Growth and Trends

The Critical Care Diagnostics Market grew from USD 1.45 billion in 2024 to USD 1.71 billion in 2025. It is expected to continue growing at a CAGR of 18.02%, reaching USD 3.92 billion by 2030. As care environments become more complex and providers demand faster, more reliable diagnostic insights, growth is propelled by the rising use of innovative instruments, enhanced reagents, advanced software, and expanded service offerings. This market is marked by the convergence of centralized laboratory solutions with point-of-care and portable technologies, real-time data integration, and shifting procurement strategies in response to global regulatory changes.

Scope & Segmentation

  • Product Types: Instruments (benchtop and portable analyzers), reagents (controls, calibrators, and kits), software, and specialized services.
  • Applications: Blood gas and electrolyte analysis; cardiac marker evaluation (CK-MB, myoglobin, troponin); hemostasis assays (APTT, D-Dimer, PT INR); infectious disease detection (bacterial and viral); and metabolite monitoring (blood glucose, lactate).
  • Technologies: Central laboratory platforms and point-of-care devices, with a growing role for integrated digital health solutions and AI-augmented workflows.
  • End Users: Ambulatory care laboratories; hospital laboratories; specialized reference centers serving both high-throughput and rapid-response diagnostic requirements.
  • Test Modes: Laboratory-based workflows and point-of-care testing models supporting both comprehensive and urgent testing scenarios.
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, and more), and Asia-Pacific (notably China, India, Japan, Australia, and additional emerging markets).
  • Companies Profiled: F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Sysmex Corporation, bioMérieux SA, Becton, Dickinson and Company, Ortho Clinical Diagnostics, Inc., and Werfen Group.

Key Takeaways for Senior Decision Makers

  • Technology is blurring the distinction between centralized laboratories and point-of-care environments, enabling rapid and informed interventions directly at the patient’s side.
  • Integrated software solutions are empowering multidisciplinary teams by streamlining data flow across devices, laboratory information systems, and electronic health records, enhancing both clinical decision support and operational efficiency.
  • Regional growth drivers vary significantly: North America leads in early adoption and digital integration, Asia-Pacific leverages local manufacturing and national initiatives, and EMEA shows a mix of advanced and cost-sensitive procurement strategies.
  • Strategic collaborations—between device manufacturers, reagent suppliers, and digital health platforms—are fostering bundled solutions that simplify procurement, training, and ongoing service management.
  • The ability to tailor workflows and product options to specific end-user segments—whether high-volume laboratories or decentralized ambulatory settings—remains critical for competitive differentiation and sustained adoption.
  • Emerging platforms with multiplexing capabilities, minimal sample requirements, and predictive analytics are expanding the reach of critical care diagnostics and supporting better patient management.

Tariff Impact: Navigating Cost and Supply Chain Challenges

Changes to United States tariffs, scheduled for implementation in 2025, are requiring market participants to reassess cost structures and supply chain strategies. Key manufacturers are seeking ways to offset import-related cost pressures through measures such as nearshoring of sensitive component production, diversifying procurement sources, and negotiating volume-based supply agreements. This has led to the rise of regional manufacturing hubs, particularly in Asia-Pacific, creating opportunities and new considerations around vendor selection and inventory management.

Methodology & Data Sources

This report utilizes a blend of in-depth primary interviews with clinical leaders, laboratory directors, and procurement experts, augmented by secondary research from peer-reviewed literature, regulatory filings, and financial disclosures. Data integrity is strengthened through cross-verification with proprietary industry databases and rigorous scenario planning to assess the market impact of 2025 tariff changes. Each trend and forecast has undergone expert panel review for accuracy and relevance.

Why This Report Matters

  • Enables leaders to identify and capitalize on new market opportunities by offering actionable segmentation insights and evaluation of technology adoption barriers.
  • Equips procurement, strategy, and R&D executives to navigate shifting global supply chains and regulatory landscapes, ensuring resilience and competitive positioning.
  • Supports informed investment and partnership decisions by profiling competitive landscapes, regional dynamics, and the integration of digital health and AI.

Primary Keyword: Critical Care Diagnostics Market

This comprehensive analysis of the Critical Care Diagnostics Market delivers actionable intelligence for companies, investors, and healthcare stakeholders committed to advancing clinical performance and operational flexibility.

Conclusion

The critical care diagnostics sector is on a transformative trajectory, shaped by innovation, regional diversification, and shifting market expectations. This report empowers executive teams to act on emerging opportunities and proactively manage strategic, operational, and regulatory changes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms for real-time ventilator weaning prediction in ICU settings
5.2. Expansion of point-of-care molecular assays for rapid pathogen identification in sepsis management
5.3. Emergence of multiplex biomarker panels enabling personalized risk stratification in critically ill patients
5.4. Adoption of wearable continuous hemodynamic monitoring devices for noninvasive vital sign tracking in critical care
5.5. Development of lab-on-a-chip platforms for rapid multi-analyte detection at the patient bedside in ICUs
5.6. Utilization of CRISPR-based diagnostic assays for ultra-sensitive detection of antimicrobial resistance genes in bloodstream infections
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Critical Care Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Benchtop Analyzers
8.2.2. Portable Analyzers
8.3. Reagents
8.3.1. Controls And Calibrators
8.3.2. Kits
8.4. Software And Services
9. Critical Care Diagnostics Market, by Application
9.1. Introduction
9.2. Blood Gas And Electrolyte Analyzers
9.3. Cardiac Marker Tests
9.3.1. CK-MB
9.3.2. Myoglobin
9.3.3. Troponin
9.4. Hemostasis Testing
9.4.1. APTT
9.4.2. D Dimer
9.4.3. PT INR
9.5. Infectious Disease Testing
9.5.1. Bacterial Detection
9.5.2. Viral Detection
9.6. Metabolite Analysis
9.6.1. Blood Glucose Monitoring
9.6.2. Lactate Monitoring
10. Critical Care Diagnostics Market, by Technology
10.1. Introduction
10.2. Central Laboratory
10.3. Point Of Care
11. Critical Care Diagnostics Market, by End User
11.1. Introduction
11.2. Ambulatory Care Laboratory
11.3. Hospital Laboratory
11.4. Reference Laboratory
12. Critical Care Diagnostics Market, by Test Mode
12.1. Introduction
12.2. Laboratory Based Testing
12.3. Point Of Care Testing
13. Americas Critical Care Diagnostics Market
13.1. Introduction
13.2. Brazil
13.3. Canada
13.4. Argentina
13.5. United States
13.6. Mexico
14. Europe, Middle East & Africa Critical Care Diagnostics Market
14.1. Introduction
14.2. France
14.3. Sweden
14.4. Netherlands
14.5. Israel
14.6. Poland
14.7. Saudi Arabia
14.8. South Africa
14.9. Russia
14.10. Spain
14.11. United Kingdom
14.12. Italy
14.13. United Arab Emirates
14.14. Denmark
14.15. Qatar
14.16. Switzerland
14.17. Norway
14.18. Nigeria
14.19. Turkey
14.20. Egypt
14.21. Finland
14.22. Germany
15. Asia-Pacific Critical Care Diagnostics Market
15.1. Introduction
15.2. Singapore
15.3. India
15.4. Indonesia
15.5. Philippines
15.6. Japan
15.7. Vietnam
15.8. Thailand
15.9. Malaysia
15.10. Australia
15.11. South Korea
15.12. Taiwan
15.13. China
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. Sysmex Corporation
16.3.7. bioMérieux SA
16.3.8. Becton, Dickinson and Company
16.3.9. Ortho Clinical Diagnostics, Inc.
16.3.10. Werfen Group
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CRITICAL CARE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CRITICAL CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CRITICAL CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CRITICAL CARE DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. CRITICAL CARE DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. CRITICAL CARE DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. CRITICAL CARE DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRITICAL CARE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BENCHTOP ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BENCHTOP ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CONTROLS AND CALIBRATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CONTROLS AND CALIBRATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BLOOD GAS AND ELECTROLYTE ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BLOOD GAS AND ELECTROLYTE ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CK-MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CK-MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APTT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APTT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY D DIMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY D DIMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PT INR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PT INR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY VIRAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY VIRAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY LACTATE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY LACTATE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 135. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 138. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 139. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 140. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 141. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 144. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 145. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 146. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 147. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 148. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 149. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 150. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 151. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 156. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 249. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 258. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 259. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 260. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 261. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 262. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 263. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 271. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 274. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 275. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 276. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 277. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 280. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 281. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 282. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 283. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 284. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 285. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 286. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 287. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 292. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 293. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 296. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKER TESTS, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMOSTASIS TESTING, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY METABOLITE ANALYSIS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Critical Care Diagnostics market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Ortho Clinical Diagnostics, Inc.
  • Werfen Group

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.92 Billion
Compound Annual Growth Rate18.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

In Vitro Diagnostic Products Market by Product Type (Instruments, Reagents, Services), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User, Test Mode - Global Forecast 2025-2030 - Product Image

In Vitro Diagnostic Products Market by Product Type (Instruments, Reagents, Services), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User, Test Mode - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
High-Density Lipoprotein Cholesterol Testing Products Market by Product Type (Analyzers, Calibrators, Controls), Technology (Enzymatic Assay, Immunoassay, NMR Spectroscopy), End User, Test Type, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

High-Density Lipoprotein Cholesterol Testing Products Market by Product Type (Analyzers, Calibrators, Controls), Technology (Enzymatic Assay, Immunoassay, NMR Spectroscopy), End User, Test Type, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Critical Care Diagnostics - Global Strategic Business Report - Product Image

Critical Care Diagnostics - Global Strategic Business Report

  • Report
  • 256 Pages
  • Global
From
Critical Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Critical Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Market

The Critical Care Diagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of critically ill patients. It includes a range of products and services, such as laboratory tests, imaging technologies, and point-of-care diagnostics. These products and services are used to detect, diagnose, and monitor a variety of conditions, including sepsis, acute respiratory distress syndrome, and other life-threatening illnesses. The Critical Care Diagnostics market is driven by the increasing prevalence of chronic and acute diseases, as well as the need for rapid diagnosis and treatment. Additionally, technological advancements in the field of diagnostics have enabled the development of more accurate and efficient diagnostic tools. Some companies in the Critical Care Diagnostics market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.